Pharmaron Beijing Co., Ltd. (FRA:17Q1)

Pharmaron Beijing Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 27, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,093	5,538	6,044	10,440	14,727	11,807
Market Cap Growth	15.92%	-8.38%	-42.11%	-29.11%	24.73%	135.07%
Enterprise Value	6,659	6,051	6,558	10,861	14,635	11,383
Last Close Price	2.18	1.69	1.56	3.96	5.41	5.44
PE Ratio	33.65	23.33	29.59	55.98	64.05	80.43
PS Ratio	3.76	3.41	4.11	7.50	14.29	18.37
PB Ratio	3.35	2.94	3.58	7.10	10.33	10.56
P/TBV Ratio	4.72	4.16	5.27	10.90	14.50	13.21
P/FCF Ratio	63.60	78.07	-	-	-	283.35
P/OCF Ratio	15.70	16.24	17.20	35.91	51.70	57.20
EV/Sales Ratio	4.06	3.73	4.46	7.80	14.20	17.71
EV/EBITDA Ratio	17.94	17.71	21.15	35.94	57.09	68.62
EV/EBIT Ratio	28.34	26.60	30.42	48.04	73.04	89.13
EV/FCF Ratio	69.51	85.31	-	-	-	273.19
Debt / Equity Ratio	0.42	0.42	0.73	0.56	0.51	0.12
Debt / EBITDA Ratio	2.08	2.17	3.71	2.59	2.72	0.75
Debt / FCF Ratio	7.98	11.15	-	-	-	3.16
Asset Turnover	0.55	0.49	0.49	0.53	0.49	0.47
Inventory Turnover	6.86	7.60	7.23	7.55	9.92	14.65
Quick Ratio	1.03	1.44	2.58	1.31	2.58	2.57
Current Ratio	1.50	1.80	2.98	1.67	2.90	2.80
Return on Equity (ROE)	9.66%	12.48%	13.14%	12.80%	16.85%	13.68%
Return on Assets (ROA)	4.91%	4.26%	4.50%	5.36%	5.97%	5.84%
Return on Invested Capital (ROIC)	8.14%	8.45%	9.59%	11.51%	15.80%	17.11%
Return on Capital Employed (ROCE)	9.40%	8.70%	7.40%	10.10%	9.40%	10.30%
Earnings Yield	2.97%	4.29%	3.38%	1.79%	1.56%	1.24%
FCF Yield	1.57%	1.28%	-0.24%	-1.05%	-0.03%	0.35%
Dividend Yield	1.04%	1.57%	1.64%	0.69%	0.51%	0.31%
Payout Ratio	34.92%	30.24%	27.78%	29.45%	17.14%	11.55%
Buyback Yield / Dilution	0.45%	0.11%	0.05%	2.40%	-1.97%	-20.06%
Total Shareholder Return	1.48%	1.68%	1.69%	3.09%	-1.46%	-19.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.